More on IMUX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $7.10 |
|
|||
| Open | $7.10 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $7.92 | ||||
| Day Low | $6.80 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 366,845 | ||||
- Immunic to present MS drug data at Toronto conference
- Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
- Form S-8 IMMUNIC, INC.
- Form 4 IMMUNIC, INC. For: Sep 16 Filed by: Nagel Robert Thorvald
- Form 4 IMMUNIC, INC. For: Sep 16 Filed by: BIOTECHNOLOGY VALUE FUND L P
- Form 8-K IMMUNIC, INC. For: Sep 10
- Immunic (IMUX) Reiterated at Buy by Stifel Post R&D Event
- H.C. Wainwright Reiterates Buy Rating on Immunic Inc. (IMUX)
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
- Form SCHEDULE 13G IMMUNIC, INC. Filed by: ORBIMED ADVISORS LLC
Entities mentioned with IMUX
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- S3 | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Show More...
